Skin Cancer Formulation

Technical Description This invention relates generally to pharmaceutical compositions for the treatment of skin cancers. The synergistic formulation comprises at least one beta caryophyllene and at least one aromadendrene oxide-2 in a ratio of about 2:1 by weight. Problems Addressed…









